News

Hims & Hers Health to offer $450M convertible senior notes
Hims & Hers Health (NYSE:HIMS) plans to offer $450M aggregate principal amount of convertible senior notes due 2030 in a private offering. The notes will accrue interest payable semi-annually in ...
Why Hims & Hers Health and LifeMD Are Skyrocketing Today
Shares of Hims & Hers Health ( HIMS -5.48%) and LifeMD ( LFMD -14.33%) are surging on Tuesday. The companie' stocks had ...
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Hims & Hers stock has risen by 20% after announcing a partnership to sell the popular weight-loss drug Wegovy.
Hims & Hers Health: Healthcare Disruptor Building A Durable Moat (Initiate With Buy)
Hims & Hers reports 111% YoY sales growth & 70%+ gross margin. Discover their growth potential, risks, & why it's a Buy ...
Breaking Down Hims & Hers Health: 13 Analysts Share Their Views
The 12-month price targets, analyzed by analysts, offer insights with an average target of $36.85, a high estimate of $68.00, ...
24/7 Wall St. on MSN2d
Hims & Hers (HIMS) Blows Out Earnings Expectations
Hims & Hers Health (NYSE:HIMS) reported a strong financial performance for Q1 2025, with revenue reaching $586 million, ...
Hims & Hers Soars Again--Explosive Growth Meets Lofty Expectations
Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...